“achaogen” Archives

in
Entry Author Date Location
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval 04/15/19 San Francisco
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel 11/09/18 National
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections 10/22/18 San Diego
Achaogen Restructures, Slashes Staff 28% as Antibiotic Launches 07/26/18 San Francisco
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs 04/25/17 San Diego
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara 06/30/14 San Diego
Achaogen Garners $72,000,000 New Round 03/12/14 San Francisco
Achaogen Secures $18,905,707 New Funding 03/25/13 San Francisco
With New Antibiotic in Hand, RQx Pharmaceuticals Looks for Partner 11/28/12 San Diego
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference 09/15/10 Boston
Tethys Pockets $33M, Achaogen’s Vision for Antibiotics, Genentech Strikes Out at FDA Panel, & More Bay Area Life Sciences News 07/23/10 San Francisco
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
The Top 10 Northern California Venture Deals of the Second Quarter—Two Ways 07/17/10 San Francisco
Kristina Burow, Arch’s Rising Star in SF, Spots Big Ideas in Biotech, Cleantech 07/16/10 San Francisco
Concur Goes Convertible, Frazier and Arch Back Achaogen, Lucid Commerce Gets Cash, & More Seattle-Area Deals News 04/14/10 Seattle
Sage Bionetworks On a Roll, Allon’s Foray into Alzheimer’s, Frazier Bets on Antibiotics, & More Seattle-Area Life Sciences News 04/08/10 Seattle
Frazier, Arch Join $56M Antibiotic Deal 04/07/10 Seattle
Achaogen Obtains $56,000,000 Series C Funding Round 04/07/10 San Francisco
Inside a Life Sciences Industry Confab: Notes from Convergence 06/17/09 Boston
Indel Therapeutics Aims High With New Class of Antibiotics to Fight Hospital Infections 03/30/09 Seattle
Follow-Up: Alnylam’s Biodefense Contract the Program’s Largest 08/10/07 Boston
Page 1 of 1

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.